Efficacy of vardenafil in human nasal mucosa

Hsing Won Wang, Li Hsiang Cheng, Fei Peng Lee

研究成果: 雜誌貢獻文章同行評審

摘要

Objective: Levitra, a phosphodiesterase-5 (PDE5) inhibitor, is the trade name of vardenafil. It is applied to treatment of erectile dysfunction. PDE5 inhibitors dilate the penile blood vessels and cause prolonged erections. However, the effects of Levitra on human nasal mucosa are not yet fully explored. Materials and methods: We examined the effectiveness of Levitra on human nasal mucosa directly in vitro by testing: 1) effect on human nasal mucosa resting tension; 2) effect on contraction caused by 10−6 M methoxamine as a sympathetic mimetic; 3) effect of the drugs on electrically induced human nasal mucosa contractions. Results: The results showed that addition of methoxamine to the incubation medium caused the nasal mucosa to contract in a dose-dependent manner. Addition of Levitra at doses of 10−4 M elicited a significant relaxation response to 10−6 M methoxamine-induced mucosa strip contraction. Levitra could not inhibit electrical field stimulation-induced spike contraction and had a minimal effect on the basal tension of nasal mucosa as the concentration increased. Conclusion: This study indicated that high concentrations of Levitra had a significant spasmolytic effect by antagonizing α-adrenoceptors. Moreover, nasal obstruction might not be relieved in patients suffering from erectile dysfunction and stuffy noses who were concomitant using α-adrenergic agonist and Levitra.
原文英語
文章編號102561
期刊American Journal of Otolaryngology - Head and Neck Medicine and Surgery
41
發行號4
DOIs
出版狀態已發佈 - 七月 1 2020

ASJC Scopus subject areas

  • 耳鼻咽喉科

指紋

深入研究「Efficacy of vardenafil in human nasal mucosa」主題。共同形成了獨特的指紋。

引用此